Story perspectives

Switzerland Cuts Medicine Prices, Sparks Access Concerns

11/7/2025

50 8

Summary

Story summary

The Swiss Federal Office of Public Health reduced prices for nearly 300 medicines by an average of 12%, saving about CHF 65 million.
The measure aims to curb healthcare expenses, particularly for cardiovascular, respiratory, and infectious diseases.
Estradot, a hormone replacement therapy, will no longer be covered by insurance after a price dispute with Sandoz.
Patients may face out-of-pocket costs, raising concerns about access to essential medications.

1 of 1

Story summary

The Swiss Federal Office of Public Health reduced prices for nearly 300 medicines by an average of 12%, saving about CHF 65 million.
The measure aims to curb healthcare expenses, particularly for cardiovascular, respiratory, and infectious diseases.
Estradot, a hormone replacement therapy, will no longer be covered by insurance after a price dispute with Sandoz.
Patients may face out-of-pocket costs, raising concerns about access to essential medications.